Atlas Trials

Evaluation of JSKN016 in the Treatment of Advanced Non-small Cell Lung Cance: a Phase II Clinical Study

Clinical trial NCT06775483 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06775483
Sponsor
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Non-small Cell Lung Cancer
Start date
2025-01-17
Primary completion
2027-06-30
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.